Bio-Techne (TECH) Gross Margin (2009 - 2026)

Bio-Techne's (TECH) quarterly Gross Margin came in at 66.88% in Q1 2026, down 97.0% year-on-year from 2229.48% in Q1 2025, and up 3.46% quarter-over-quarter from 64.65% in Q4 2025.

Bio-Techne (TECH) Gross Margin (2009 - 2026) Analysis & Trends

Bio-Techne's Gross Margin history runs 18 years deep, the most recent figure standing at 66.88% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 97.0% year-over-year to 66.88% in Q1 2026; TTM through Mar 2026 was 64.96%, a 80.0% decrease from a year earlier, with the FY2025 full-year figure at 64.8%, down 161.0% from the prior year.
  • Gross Margin grew to 66.88% in Q1 2026 per TECH's latest filing, from 64.65% in the prior quarter.
  • Across five years, Gross Margin topped out at 8979.75% in Q3 2022 and bottomed at 62.72% in Q2 2025.
  • The 5-year median for Gross Margin is 66.88% (2026), against an average of 590.86%.
  • Across the five-year window, Gross Margin soared 891340 bps in 2022 and slumped 891288 bps in 2023, its largest moves.
  • Year by year, Gross Margin stood at 67.52% in 2022, then fell by 4 bps to 64.78% in 2023, then gained by 1 bps to 65.27% in 2024, then fell by 1 bps to 64.65% in 2025, then advanced by 3 bps to 66.88% in 2026.
  • Per Business Quant, the three latest TECH Gross Margin figures stand at 66.88% (Q1 2026), 64.65% (Q4 2025), and 65.65% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 66.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 66.88%
Dec 31, 2025 64.65%
Sep 30, 2025 65.65%
Jun 30, 2025 62.72%
Mar 31, 2025 67.86%
Dec 31, 2024 65.27%
Sep 30, 2024 63.23%
Jun 30, 2024 66.43%
Mar 31, 2024 67.43%
Dec 31, 2023 64.78%
Sep 30, 2023 66.87%
Jun 30, 2023 67.93%
Mar 31, 2023 68.73%
Dec 31, 2022 67.52%
Sep 30, 2022 8,979.75%
Jun 30, 2022 69.51%
Mar 31, 2022 69.38%
Dec 31, 2021 68.22%
Sep 30, 2021 66.35%
Jun 30, 2021 67.92%